Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells

被引:26
作者
Baba, M [1 ]
Okamoto, M
Kashiwaba, N
Ono, M
机构
[1] Kagoshima Univ, Fac Med, Div Human Retroviruses, Ctr Chron Viral Dis, Kagoshima 890, Japan
[2] Kaken Shoyaku Co, Res Labs, Tokyo, Japan
关键词
cepharanthine; alkaloid; HIV-1; structure-activity relationship; chronic infection; U1cells;
D O I
10.1177/095632020101200506
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cepharanthine (12-O-methyl cepharanoline) is a plant alkaloid and has been shown to inhibit tumour necrosis factor-alpha- or phorbol 12-myristate 13-acetate-induced HIV-1 replication in the chronically infected promonocytic cell line, U1. Its mechanism of action is considered to be the inhibition of nuclear factor kappaB, a potent inducer of HIV-1 gene expression. In this study, we have synthesized 96 derivatives of cepharanoline, including cepharanthine, and examined their inhibitory effects on HIV-1 replication in U1 cells. Among the 12-O-alkyl derivatives, cepharanthine proved to be the most active, and the activity decreased as the length of the alkyl chain increased. All of the 12-O-acyl derivatives were totally inactive, while a few 12-O-carbamoyl derivatives displayed modest activity. Since 12-O-ethyl derivatives were found to be as active as cepharanthine against HIV-1 replication, we further synthesized various 12-O-ethyl derivatives of cepharanoline. Among the derivatives, five proved to be more active inhibitors than cepharanthine, and the most active compound was 12-O-ethylpiperazinyl cepharanoline. The 50% effective concentrations of this compound and cepharanthine were 0.0041 and 0.028 mug/ml (0.0060 and 0.046 muM), respectively.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 20 条
  • [1] Baba M, 2001, ANTIRETROVIRAL THERAPY, P191
  • [2] Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives
    Baba, M
    Okamoto, M
    Makino, M
    Kimura, Y
    Ikeuchi, T
    Sakaguchi, T
    Okamoto, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1250 - 1255
  • [3] Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities
    Butera, ST
    [J]. ANTIVIRAL RESEARCH, 2000, 48 (03) : 143 - 176
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY
    BUTERA, ST
    ROBERTS, BD
    LAM, L
    HODGE, T
    FOLKS, TM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (04) : 2726 - 2730
  • [5] Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line
    Emiliani, S
    Fischle, W
    Ott, M
    Van Lint, C
    Amella, CA
    Verdin, E
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1666 - 1670
  • [6] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE NERVOUS-SYSTEM - PATHOGENETIC MECHANISMS
    EPSTEIN, LG
    GENDELMAN, HE
    [J]. ANNALS OF NEUROLOGY, 1993, 33 (05) : 429 - 436
  • [7] CYTOKINE-INDUCED EXPRESSION OF HIV-1 IN A CHRONICALLY INFECTED PROMONOCYTE CELL-LINE
    FOLKS, TM
    JUSTEMENT, J
    KINTER, A
    DINARELLO, CA
    FAUCI, AS
    [J]. SCIENCE, 1987, 238 (4828) : 800 - 802
  • [8] CEPHARANTHINE (BISCOCLAURINE ALKALOID) TREATMENT IN ENDOTOXIC-SHOCK OF SUCKLING RATS
    GOTO, M
    ZELLER, WP
    HURLEY, RM
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (08) : 589 - 591
  • [9] ACTIVATION OF HIV GENE-EXPRESSION DURING MONOCYTE DIFFERENTIATION BY INDUCTION OF NF-KAPPA-B
    GRIFFIN, GE
    LEUNG, K
    FOLKS, TM
    KUNKEL, S
    NABEL, GJ
    [J]. NATURE, 1989, 339 (6219) : 70 - 73
  • [10] KONDO Y, 1992, INT J IMMUNOPHARMACO, V14, P1181